Baxter International Medical Device Company Intelligence Report

Product Code ESP00070
Publication Date November 2010
Publisher Espicom
Product Type Report
Pages 44
ISBN Number not applicable

Baxter International Medical Device Company Intelligence Report

Baxter International Inc develops, manufactures and markets products for the treatment of haemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The company applies a combination of expertise in medical devices, pharmaceuticals and biotechnology and operates in three segments:

Medication Delivery – manufactures intravenous (IV) solutions and administration sets, pre-mixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps and inhalation anaesthetics, as well as products and services related to pharmacy compounding, drug formulation and packaging technologies.

Renal – provides products to treat end-stage renal disease, or irreversible kidney failure. The business manufactures solutions and other products for peritoneal dialysis (PD), a home-based therapy, and also distributes products for haemodialysis (HD), which is generally conducted in a hospital or clinic. This business segment was expanded in September 2009 with the acquisition of certain assets relating to Edwards Lifesciences’ continuous renal replacement therapy (CRRT) product line.

BioScience – processes recombinant and plasma-based proteins to treat haemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. In March 2010, Baxter acquired ApaTech, which provided Baxter with immediate entry into the emerging bone fusion field.

This profile primarily concentrates on Baxter’s medical device activities.

Baxter has approximately 49,700 employees and conducts business in over 100 countries. In 2009, the company reported revenues of US$12.56 billion, of which approximately 58% were generated outside of the US. Baxter maintains manufacturing and distribution facilities in a number of locations in the US, Europe, Canada, Asia-Pacific and Latin America.

This company report provides

Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format

Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location

Strategic Focus
Investigates the company’s aims and its areas of focus

Products
Core product areas, key brands, product approvals and launches Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?

Manufacturing and Distribution
Identifying the company’s manufacturing locations
Sales and marketing facilities

Agreements
With whom has the company reached agreements and what do they involve?
Key contracts awarded

Mergers, Acquisitions, Minority Investments and Divestments

Litigation

Key Corporate Events

BioScience – manufactures recombinant and plasma-based proteins to treat haemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. 

Prior to the divestiture of the Transfusion Therapies (TT) business in February 2007, the BioScience segment also manufactured manual and automated blood and blood-component separation and collection systems.
 
This profile mainly concentrates on Baxter’s medical device activities.

Baxter has approximately 48,500 employees and conducts business in over 100 countries. The company generates approximately 60% of its revenues outside of the US, and maintains manufacturing and distribution facilities in a number of locations in the US, Europe, Canada, Asia, Latin America and Australia.

Contents

OVERVIEW

FINANCIAL REVIEW
First Half 2010 Financial Results
BioScience Division
Medication Delivery Division
Colleague Infusion Pump Recall
Renal Division
2009 Financial Results
BioScience Division
Medication Delivery Division
Renal Division
Five-Year Financial Data
Outlook
Employees

STRATEGIC FOCUS
PRODUCTS
Medication Delivery
Renal
PD Solutions
Automated Peritoneal Dialysis (APD) and Continuous Ambulatory Peritoneal Dialysis (CAPD) Products
HD Products
CRRT
BioScience
Regenerative Medicine
BioSurgery

RESEARCH AND DEVELOPMENT
Trials and Studies
Research Agreements
Kuros Biosurgery
KUR-111
KUR-112
KUR-113

MANUFACTURING AND DISTRIBUTION

AGREEMENTS
Nikkiso
SIGMA International General Medical Apparatus
Angiotech Pharmaceuticals
Innocoll Pharmaceuticals
Nycomed
Pfizer
DEKA Research & Development and HHD
Intercytex (now Healthpoint)
Spinal Restoration
Vectura
Gambro
Zimmer
Miltenyi Biotec
Mayo Clinic
Becton Dickinson
Baxter International Table of Contents
Minntech
Med Enclosure

MERGERS AND ACQUISITIONS
ApaTech
Assets Relating to Edwards Lifesciences’ CRRT Product Line
Willow Healthcare Services
MAAS Medical
Spinal Restoration
Epic Therapeutics
Wockhardt Life Sciences’ IV Fluids Business
Fusion Medical Technologies
Autros Healthcare Solutions
Asta Medica Onkologie
Nexell Therapeutics’ Cell Processing Products
Cook Pharmaceutical Solutions
Dade Behring’s Technical Service Operations
Sera-Tec Biologicals
Orion’s Intravenous Infusion and Nutrition Businesses
Althin Biopharm
Althin Medical
Sabratek’s Infusion Pump Business and Rocap Product Line
Pharmacia & Upjohn’s German Nutrition Business
Bieffe Medital’s IV Therapy and Irrigating Solutions Business
Clintec Nutrition Business

MINORITY INVESTMENTS
Sigma International

DIVESTITURES
Transfusion Therapies Business
Disposable Airway Management Business
Renal Service Businesses
PFC Therapeutics
Admixture Products and Services
Edwards Japan
Cardiovascular Business
Productivity Systems Business Assets
Sure-Med
Industrial and Life Sciences Division
Diagnostic Products Manufacturing Operations
Tower Packaging Business
Caremark

JOINT VENTURES
Eczacibasi Baxter Hospital Supply Products Company

LITIGATION
Fresenius
Peritoneal Dialysis Litigation
Haemodialysis Litigation
KEY CORPORATE EVENTS

List of tabLes
SUMMARY OPERATING  RESULTS
Recent Key Events
Baxter - 2010 Quarterly Financial Results
Baxter - 2010 Quarterly Net Sales by Business Segment and Geographic Area
Baxter BioScience Division - 2010 Quarterly Net Sales by Product Sector
Baxter Medication Delivery Division - 2010 Quarterly Net Sales by Product Sector
Baxter Renal Division - 2010 Quarterly Net Sales by Product Sector
Baxter - Annual Financial Results, 2005-2009
Baxter - Annual Net Sales by Business Segment and Geographic Area, 2005-2009
Baxter BioScience Division - Annual Net Sales and Pre-tax Income, 2005-2009
Baxter Medication Delivery Division - Annual Net Sales and Pre-tax Income, 2005-2009
Baxter Renal Division Annual Net Sales and Pre-tax Income, 2005-2009
Baxter – Five-Year Financial Summary
(years ended 31st December, US$ million)
Baxter – Global Location of Employees, 2007-2009
Baxter – Summary of Medical Delivery Medical Device Products
Baxter – Summary of Renal Medical Device Products
Baxter – Summary of BioSurgery Products
Baxter - Annual R&D Expenses, 2005-2009
Baxter – Medical Device R&D Pipeline
Baxter’s Principal Manufacturing Facilities by Segment, December 2009
Agreements Summary
Mergers and Acquisitions Summary

List of Charts
Baxter - Annual Net Sales and Operating Income, 2005-2009
Baxter - Annual Sales by Business Sector, 2005-2009
Baxter - Annual Sales by Geographic Area, 2005-2009
Baxter BioScience Division Sales by Product Sector, 2005-2009
Baxter Medication Delivery Division - Annual Sales by Product Sector, 2005-2009
Baxter Renal Division - Annual Sales by Product Sector, 2005-2009
Baxter - 2009 Sales of Medical Delivery Products
Top 5 Dialysis Providers Worldwide, 2009
Baxter - 2009 Renal Product Sales
Baxter - 2009 BioScience Product Sales